T o win a national bid to host a new European research facility is, for academics, akin to being chosen to hold the Olympic Games. The warm glow of prestige is matched by the flow of hard cash to regenerate land and communities, while the rush of the best scientific minds to the new equipment can give a major boost to national research performance.
So the Czech Republic, Hungary and Romania are rightly proud to have beaten France and the United Kingdom to jointly host the €800-million (US$1-billion) Extreme Light Infrastructure (ELI), a Y ou may have seen claims that scientists at NASA have discovered a bacterium that can replace the phosphorus in its DNA with arsenic. You may have heard that this could help the hunt for aliens. You may even have heard that the 'arsenic bacterium' is itself an alien. What you will not have seen or heard is a detailed response from NASA and the scientists involved to online criticism of their work. In the face of worldwide attention on their paper (F. WolfeSimon et al. Science doi:10.1126/science.1197258; 2010) , which NASA and the team deliberately courted, the researchers have stuck their heads in the digital sand.
In response to the arsenic bacterium claims, bloggers and researchers raised serious and thoughtful reservations about the paper's methodology and findings. But the authors say that they will not engage with these critics, or with science journalists drawn to the controversy, because such discussion should be moderated in the peer-reviewed literature. Meanwhile, they are urging other scientists to work to replicate their results -a process that will take many months. "We are not going to engage in this sort of discussion, " Felisa Wolfe-Simon, the paper's lead author and a NASA astrobiology research fellow at the US Geological Survey in Menlo Park, California, told one Nature reporter, "Any discourse will have to be peer-reviewed in the same manner as our paper was, and go through a vetting process so that all discussion is properly moderated. "
Purists who hold peer review as the casting vote in such debates will read her words with approval. But the problem is that WolfeSimon's reticence is the polar opposite of the fanfare with which NASA trailed her discovery to the public. In an advance press advisory on 29 November, NASA trumpeted an "astrobiology finding that will impact the search for evidence of extraterrestrial life". At a press conference to coincide with the paper's publication, the authors reported a more down-to-Earth, but nonetheless radical, discovery, claiming that an arsenic-tolerant bacterium had rewritten the rules of life as we know them.
Such claims were always likely to bring intensive scrutiny, especially as many scientists think that NASA has form for making extravagant claims in the field of astrobiology. Within two days of the paper appearing, Rosie Redfield, a microbial geneticist at the University of British Columbia in Vancouver, Canada, published a long and detailed critique of what she described as the paper's methodological shortcoming on her blog (go.nature.com/ddesjw). She was one of several researchers who used their blogs to question whether the paper's data supported its claims. It was at this point that the authors, previously happy to promote their findings, refused to answer further questions and retreated behind the walls of peer review.
Formal peer review does give criticized authors time to think critically and carefully, and it is a good way to filter out rubbish. But in this case, much of the criticism was already coming from the researchers' peers. And it should be remembered that peer review as conducted by journals
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Blogs and online comments can provide valuable feedback on newly published research. Scientists need to adjust their mindsets to embrace and respond to these new forums for debate.
is itself full of differing opinions, and is not the only way to crystallize truth from such disputes. In this instance, a prompt and explicitly provisional response from the authors would have been a better approach, particularly given the way they encouraged the original attention.
Nature strongly encourages post-publication discussion on blogs and online commenting facilities as a complement to -but not a substitute for -conventional peer review. Yet it is true that so far online commenting and blogs have generally contributed little. Of the thousands of papers published every year, only a few attract substantive comments. And, regrettably, it seems that even those meagre comments rarely spark debate: a study of medical articles in the BMJ last August found that few authors bothered to respond to online criticisms of their papers (P. C. Gøtzsche et al. Br. Med. J. 341, c3926; 2010) .
Bloggers and online commentators have an important part to play in the assessment of research findings, and many researchers' blogs, in particular, contain better analyses of the true significance of a scientific finding or debate than is seen in much of the mainstream media. Science journalists who repeated NASA's claims on the arsenic bacterium and did not tap into the widespread criticisms, did little to defend themselves from claims of reporting by press release. Blogging scientists, meanwhile, should remember that such informal forums do not excuse insults and casual discourtesy towards colleagues -especially those being urged to respond.
In the end, the scientific truth will prevail, as it usually does. In the meantime, researchers must accept some harsh truths about the speed and spread of digital criticism. go.nature.com/xhunqv consortium of three independent laser facilities to deliver images at the atomic level.
The project is part of a roadmap for European research infrastructure -a wish list of research facilities drawn up by the best scientific minds across the European Union (EU) -and the first to be built in newer, and often less-well-off, member states.
The ELI is on track to begin construction early next year, but the real test starts now. To build it, the host countries will use EU structural funds -a multi-billion-euro pot established to help narrow the economic and social disparities between member states. Earlier this year, Máire Geoghegan-Quinn, European Commissioner for Research, Innovation and Science, said she hoped to divert €86 billion of EU structural funds to building Europe's "knowledge economy", including research infrastructure. In the past, it has been difficult to track how countries have spent such structural funds, and this lack of transparency has led to a sense of mistrust. As a result, policy wonks in established member states are questioning the merits of using structural funds to support research in Europe, such as on the ELI.
Poland is a major beneficiary of structural funding for research infrastructure, and has been allocated €1 billion over the period [2007] [2008] [2009] [2010] [2011] [2012] [2013] . Critics of the approach were handed ammunition earlier this year, when Poland invited a panel of international scientists to assess the research infrastructure it wants to build in the future, partly using structural funds. The country should be applauded for its scientifically responsible approach. But some of the experts on the panel have some concerns about the scientific quality of the country's proposals.
Some projects look more like plans to create networks between national universities, they say, or attempts to build and strengthen national industries, rather than to develop cutting-edge research infrastructures. One project aims to build a knowledge alliance between several universities to help develop foundry and metallurgy industries, but contains no ideas for what research would be conducted in this area. Instead, it focuses on how the institutions can be linked up easily, sited as they are along major highways.
Out of a total of 60 points that each proposal could be awarded, the highest mark was 45.3; the majority of projects came in at just over half marks. As one scientist on the assessment panel (from a research-intensive member state) commented, only projects awarded the equivalent of 54 points or more would be considered for funding in their home nation. There are also widespread concerns in Europe that the new member states lack the experience to manage large infrastructure projects, including handling budgets, procurement and legal aspects. Insiders at the ELI say that this lack of experience is beginning to show, in preparing accounts for example. The European Research Advisory Board, an independent advisory committee to the European Commission, echoes these fears in a report published in October. The board is concerned that the power given to member states, to decide which projects to fund with structural funds, directs investment towards building national capacity, rather than cutting-edge research. The board recommends that some of the structural funds be held back in a central pot, to be allocated to projects judged to be of a high standard by experts, and which would serve pan-European needs. Although this approach may be better for research as a whole, it doesn't address the difficulties faced in the new member states.
These difficulties are not confined to the newer member states, as those countries involved in building ITER, the fusion test reactor struggling to life near Cadarache, France, have learnt the hard way. Legal and managerial expertise that is crucial to make such projects work must be actively sought and shared. For example, the European Investment Bank's initiative to help new member states prepare financial proposals for major projects could be extended to see projects through to later stages. And a portion of structural funds earmarked for research infrastructure could be set aside to train scientists as managers.
Structural funds for research infrastructure should continue to flow, but more international support is needed to ensure that the structures built around them are sound. ■ "Some Polish research infrastructure projects look like attempts to build national industries."
Asbestos scandal
Irresponsible policies could cause an epidemic of malignant lung disease. V iewed through an electron microscope, asbestos fibres look like thin glass straws, some no more than a fraction of a micro metre wide. If inhaled, they penetrate the soft alveoli of the lungs and the membranes that line the chest cavity. And there they stay. Over time, damaged cells can cause a malignant disease called mesothelioma, which often kills people, horribly, less than a year after diagnosis.
Before the widespread industrial use of asbestos began in the late nineteenth century, malignant meso thelioma was unheard of, yet it is now responsible for tens of thousands of deaths around the world every year. After the link between asbestos exposure and the disease was convincingly made in 1960, responsible nations eventually took strong measures to remove the mineral from commercial products and to halt mining and export. Less responsible nations did not; this is a scandal that deserves wider attention.
The United States has still not banned asbestos, despite the millions of dollars spent to clear it from homes and from communities near mines. And Canada has been criticized for plans to expand asbestos mining operations, which export the material to India, Indonesia and the Philippines. Although Canada enforces strict guidelines on asbestos use at home to protect its own people, those in countries to which it sends the mineral have little or no protection. Asbestos exported from Canada and other countries including Russia, Brazil and Kazakhstan is routinely mixed into building materials and consumer products, prized for the same durability that makes it troublesome for living tissue. Owing to the long time between exposure and the onset of disease, 30 years or more, the asbestos trade in North America and elsewhere is creating an epidemic that may take decades to peak and subside.
The minerals industry has long tried to convince regulators that white asbestos -or chrysotile -is safe when handled properly. It argues that only the already controlled forms -blue and brown asbestos, known collectively as amphibole -are of concern.
To support this, industry advocates point to scientific data and studies. Yet although the relevant literature is a mire of conflicting results, this should not be seen as an endorsement of their position. Rather, it reflects a string of industry-sponsored studies designed only to cast doubt on the clear links between chrysotile and lung disease. These are familiar tactics and several countries, including Britain, have seen through them and made the correct decision to ban all forms of asbestos, all of which have been proven to be carcinogenic in humans.
Meanwhile, researchers are finding new causes for concern with other natural fibrous minerals such as erionite (see page 884). Complacency is the problem. Much of the developed world has seen asbestos removed from public spaces, leaving in many minds a false sense of security. The public should once again be made aware of the risks associated with exposure to mineral fibres, as well as some man-made fibres. And governments must ban the extraction, processing and use of materials that can cause serious disease. ■
